BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36284375)

  • 41. Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation.
    Trivedi A; Mehrotra A; Baum CE; Lewis B; Basuroy T; Blomquist T; Trumbly R; Filipp FV; Setaluri V; de la Serna IL
    Epigenetics Chromatin; 2020 Mar; 13(1):14. PubMed ID: 32151278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis.
    Roberts TC; Etxaniz U; Dall'Agnese A; Wu SY; Chiang CM; Brennan PE; Wood MJA; Puri PL
    Sci Rep; 2017 Jul; 7(1):6153. PubMed ID: 28733670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.
    Rahman S; Sowa ME; Ottinger M; Smith JA; Shi Y; Harper JW; Howley PM
    Mol Cell Biol; 2011 Jul; 31(13):2641-52. PubMed ID: 21555454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells.
    Momeny M; Eyvani H; Barghi F; Ghaffari SH; Javadikooshesh S; Hassanvand Jamadi R; Esmaeili F; Alishahi Z; Zaghal A; Bashash D; Samani FS; Ghaffari P; Dehpour AR; Tavangar SM; Alimoghaddam K; Ghavamzadeh A
    Anticancer Drugs; 2018 Nov; 29(10):1011-1020. PubMed ID: 30096128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.
    Zhang Z; Ma P; Jing Y; Yan Y; Cai MC; Zhang M; Zhang S; Peng H; Ji ZL; Di W; Gu Z; Gao WQ; Zhuang G
    Theranostics; 2016; 6(2):219-30. PubMed ID: 26877780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional coordination of BET family proteins underlies altered transcription associated with memory impairment in fragile X syndrome.
    Kim SK; Liu X; Park J; Um D; Kilaru G; Chiang CM; Kang M; Huber KM; Kang K; Kim TK
    Sci Adv; 2021 May; 7(21):. PubMed ID: 34138732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma.
    Markman RL; Webber LP; Nascimento Filho CHV; Reis LA; Vargas PA; Lopes MA; Zanella V; Martins MD; Squarize CH; Castilho RM
    Cell Oncol (Dordr); 2019 Apr; 42(2):143-155. PubMed ID: 30539410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC.
    Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S
    J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes.
    Xiao Y; Liang L; Huang M; Qiu Q; Zeng S; Shi M; Zou Y; Ye Y; Yang X; Xu H
    Rheumatology (Oxford); 2016 Jan; 55(1):173-84. PubMed ID: 26324948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation.
    Zhang M; Wang B; Urabe G; Huang Y; Plutzky J; Kent KC; Guo LW
    Cell Signal; 2019 Sep; 61():20-29. PubMed ID: 31075399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function.
    Cribbs AP; Filippakopoulos P; Philpott M; Wells G; Penn H; Oerum H; Valge-Archer V; Feldmann M; Oppermann U
    Front Immunol; 2021; 12():626255. PubMed ID: 33717143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The conserved 12-amino acid stretch in the inter-bromodomain region of BET family proteins functions as a nuclear localization signal.
    Fukazawa H; Masumi A
    Biol Pharm Bull; 2012; 35(11):2064-8. PubMed ID: 22971749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ARV-825 Demonstrates Antitumor Activity in Gastric Cancer
    Liao X; Qian X; Zhang Z; Tao Y; Li Z; Zhang Q; Liang H; Li X; Xie Y; Zhuo R; Chen Y; Jiang Y; Cao H; Niu J; Xue C; Ni J; Pan J; Cui D
    Front Oncol; 2021; 11():753119. PubMed ID: 34733788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging roles of BET proteins in transcription and co-transcriptional RNA processing.
    Eischer N; Arnold M; Mayer A
    Wiley Interdiscip Rev RNA; 2023 Jan; 14(1):e1734. PubMed ID: 35491403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins.
    Lai J; Liu Z; Zhao Y; Ma C; Huang H
    Front Oncol; 2021; 11():716830. PubMed ID: 34540687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.
    Picaud S; Da Costa D; Thanasopoulou A; Filippakopoulos P; Fish PV; Philpott M; Fedorov O; Brennan P; Bunnage ME; Owen DR; Bradner JE; Taniere P; O'Sullivan B; Müller S; Schwaller J; Stankovic T; Knapp S
    Cancer Res; 2013 Jun; 73(11):3336-46. PubMed ID: 23576556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling.
    Andrieu G; Tran AH; Strissel KJ; Denis GV
    Cancer Res; 2016 Nov; 76(22):6555-6567. PubMed ID: 27651315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
    Kling MJ; Kesherwani V; Mishra NK; Alexander G; McIntyre EM; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    J Exp Clin Cancer Res; 2022 Nov; 41(1):321. PubMed ID: 36357906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
    Zhang P; Wang D; Zhao Y; Ren S; Gao K; Ye Z; Wang S; Pan CW; Zhu Y; Yan Y; Yang Y; Wu D; He Y; Zhang J; Lu D; Liu X; Yu L; Zhao S; Li Y; Lin D; Wang Y; Wang L; Chen Y; Sun Y; Wang C; Huang H
    Nat Med; 2017 Sep; 23(9):1055-1062. PubMed ID: 28805822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression.
    Zhou B; Hu J; Xu F; Chen Z; Bai L; Fernandez-Salas E; Lin M; Liu L; Yang CY; Zhao Y; McEachern D; Przybranowski S; Wen B; Sun D; Wang S
    J Med Chem; 2018 Jan; 61(2):462-481. PubMed ID: 28339196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.